HSBC Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$150M Buy
511,067
+4,563
+0.9% +$1.5M 0.08% 244
2025
Q4
$178M Sell
506,504
-3,462
-0.7% -$1.17M 0.09% 203
2025
Q3
$165M Sell
509,966
-47,558
-9% -$14.8M 0.09% 205
2025
Q2
$217M Sell
557,524
-123,930
-18% -$49.8M 0.13% 145
2025
Q1
$296M Sell
681,454
-79,350
-10% -$31.9M 0.18% 101
2024
Q4
$281M Buy
760,804
+32,736
+4% +$13.7M 0.16% 101
2024
Q3
$378M Sell
728,068
-157,886
-18% -$84.3M 0.22% 74
2024
Q2
$480M Buy
885,954
+52,121
+6% +$27.6M 0.29% 56
2024
Q1
$432M Buy
833,833
+123,988
+17% +$61.7M 0.29% 58
2023
Q4
$334M Sell
709,845
-202,041
-22% -$93.4M 0.29% 57
2023
Q3
$399M Buy
911,886
+25,412
+3% +$11.5M 0.42% 38
2023
Q2
$394M Buy
886,474
+357,693
+68% +$165M 0.4% 41
2023
Q1
$243M Buy
528,781
+43,482
+9% +$20.7M 0.29% 59
2022
Q4
$249M Buy
485,299
+147,462
+44% +$74.9M 0.29% 62
2022
Q3
$154M Buy
337,837
+91,940
+37% +$44M 0.25% 67
2022
Q2
$119M Buy
245,897
+55,697
+29% +$27.6M 0.17% 102
2022
Q1
$94.5M Sell
190,200
-17,449
-8% -$7.98M 0.11% 151
2021
Q4
$96.7M Sell
207,649
-84,309
-29% -$35.5M 0.09% 203
2021
Q3
$111M Buy
291,958
+46,707
+19% +$17.8M 0.11% 149
2021
Q2
$93.5M Sell
245,251
-25,595
-9% -$9.78M 0.1% 188
2021
Q1
$98.2M Sell
270,846
-67,021
-20% -$21.6M 0.12% 167
2020
Q4
$107M Buy
337,867
+99,182
+42% +$30.4M 0.14% 134
2020
Q3
$63.5M Buy
238,685
+52,847
+28% +$14.2M 0.1% 174
2020
Q2
$48.9M Sell
185,838
-32,586
-15% -$8.69M 0.09% 189
2020
Q1
$50M Sell
218,424
-3,599
-2% -$981K 0.12% 158
2019
Q4
$66.9M Sell
222,023
-8,480
-4% -$2.33M 0.12% 162
2019
Q3
$55.3M Buy
230,503
+70,067
+44% +$19.2M 0.1% 196
2019
Q2
$45.3M Sell
160,436
-68,490
-30% -$18.7M 0.09% 228
2019
Q1
$65.7M Buy
228,926
+46,334
+25% +$13.4M 0.12% 176
2018
Q4
$48M Sell
182,592
-24,848
-12% -$6.83M 0.09% 227
2018
Q3
$56.8M Sell
207,440
-24,397
-11% -$6.33M 0.09% 215
2018
Q2
$55.2M Sell
231,837
-4,295
-2% -$995K 0.1% 174
2018
Q1
$51.9M Sell
236,132
-49,277
-17% -$11.6M 0.08% 245
2017
Q4
$64.2M Sell
285,409
-15,586
-5% -$3.32M 0.09% 192
2017
Q3
$57.2M Buy
300,995
+26,056
+9% +$4.96M 0.09% 194
2017
Q2
$51.7M Sell
274,939
-87,120
-24% -$15.7M 0.1% 201
2017
Q1
$60.1M Buy
362,059
+53,868
+17% +$8.57M 0.13% 147
2016
Q4
$44.3M Buy
308,191
+25,284
+9% +$3.39M 0.1% 214
2016
Q3
$35.4M Buy
282,907
+7,274
+3% +$939K 0.09% 255
2016
Q2
$36.2M Buy
275,633
+36,247
+15% +$4.96M 0.1% 231
2016
Q1
$33.3M Sell
239,386
-5,451
-2% -$728K 0.09% 248
2015
Q4
$34.2M Sell
244,837
-201,639
-45% -$27.8M 0.08% 274
2015
Q3
$62.4M Buy
446,476
+138,634
+45% +$20.8M 0.16% 134
2015
Q2
$50.5M Sell
307,842
-60,030
-16% -$9.59M 0.1% 207
2015
Q1
$56.9M Sell
367,872
-25,200
-6% -$3.59M 0.11% 193
2014
Q4
$49.6M Buy
393,072
+89,057
+29% +$11M 0.1% 213
2014
Q3
$36.4M Buy
304,015
+40,718
+15% +$4.67M 0.08% 259
2014
Q2
$28.3M Sell
263,297
-93,236
-26% -$9.61M 0.06% 321
2014
Q1
$35.5M Sell
356,533
-1,201,406
-77% -$109M 0.08% 237
2013
Q4
$144M Buy
1,557,939
+1,289,807
+481% +$115M 0.37% 49
2013
Q3
$22.4M Sell
268,132
-94,716
-26% -$8.12M 0.06% 354
2013
Q2
$29.7M Buy
+362,848
New +$27.2M 0.09% 242

Other funds holding ELV

HSBC Holdings's ELV Position: Q1 2026 in Review

HSBC Holdings increased its Elevance Health (ELV) stake by 0.9% in Q1 2026, buying an estimated $1.5M and bringing the position to 511,067 shares worth $150M. The position accounts for 0.08% of the portfolio, ranked #244.

HSBC Holdings first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $480M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • HSBC Holdings held 511,067 shares of Elevance Health worth $150M as of Q1 2026.
  • HSBC Holdings bought 4,563 Elevance Health shares in Q1 2026, an estimated $1.5M.
  • Elevance Health made up 0.08% of HSBC Holdings's portfolio in Q1 2026, its #244 holding.
  • HSBC Holdings first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's Elevance Health position peaked at $480M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.